Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel-Group, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of a Zinc-Containing Dietary Supplement (Biolizin) in Improving Functional Poor Appetite in Children Aged 6 to 36 Months

NCT07153549 is registered in ClinicalTrials.gov with Haiphong University of Medicine and Pharmacy as lead sponsor.

NCT NCT07153549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07153549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel-Group, Randomized, Open-Label, Controlled Study to Evaluate the Efficacy and Safety of a Zinc-Containing Dietary Supplement (Biolizin) in Improving Functional Poor Appetite in Children Aged 6 to 36 Months
Lead sponsor
Haiphong University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Recruiting
Start date
September 20, 2025
Completion date
April 30, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appetite disorders, feeding and eating disorders of childhood, functional poor appetite